Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue [EXTENSION OF 700012063]
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2015
At a glance
- Drugs Dutasteride (Primary)
- Indications Benign prostatic hyperplasia; Prostate cancer
- Focus Pharmacodynamics
- 01 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 01 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 18 Apr 2014 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016, as per ClinicalTrials.gov record.